BOUT
Innovator IBD Breakout Opportunities ETF
The innovator IBD Breakout Opportunities ETF tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors. The fund may hold 50% T-bills based on technical market signals.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 16.2 M
ASSETS UNDER MGMT
81 bp
EXPENSES
Fund Basics
| Inception date | Sep 12, 2018 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| SANDISK CORP | 2.6 % |
| RUSH STREET INTERACTIVE, INC. CLASS A | 2.5 % |
| AXOGEN, INC. | 2.3 % |
| IRON MOUNTAIN INC | 2.3 % |
| GOLAR LNG LTD | 2.2 % |
| HMH HOLDING INC | 2.2 % |
| JANUS LIVING INC | 2.2 % |
| MAPLIGHT THERAPEUTICS INC | 2.2 % |
| INTEL CORP | 2.2 % |
| SOLV ENERGY INC | 2.2 % |
Constituent Breakdown
| Number of holdings | 76 |
| Herfindahl-Hirschman Index | 163 |
| Wgt avg mkt cap (mns) | $302,179 |
| Large cap (>$10bn) | 37.0% |
| Mid cap ($2-10bn) | 35.2% |
| Small cap (<$2bn) | 15.3% |
| Developed mkts. | 91.3% |
| Emerging mkts. | 0.5% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 76.2 % |
 |
CANADA | 2.6 % |
 |
BERMUDA | 2.2 % |
 |
PUERTO RICO | 2.1 % |
 |
AUSTRALIA | 2.1 % |
 |
IRELAND | 1.5 % |
 |
SWITZERLAND | 1.4 % |
 |
HONG KONG | 0.9 % |
 |
CHILE | 0.6 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 24.8% | 34.8% | 16.0% | 13.7% | 5.6% | -- | -- | 8.2% |
| Dividend Yield | 0.0% | 0.0% | 0.3% | 0.7% | 0.7% | -- | -- | 0.5% |
| Total Returns | 24.8% | 34.8% | 16.4% | 14.4% | 6.3% | -- | -- | 8.7% | Ann. Volatility | 24.8% | 20.3% | 20.5% | 18.9% | 19.6% | -- | -- | 23.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.22 | 56% |
| MSCI EAFE | 0.88 | 40% |
| MSCI Emg Mkts | 0.73 | 44% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 0.6% |
| Avg. Bid/Ask (% of price) | 0.43% |
Technical Indicators
| 30d moving avg. (EMA) | $42.48 |
| Relative strength (RSI) | 65 |
| MACD/Signal | 1.19/1.08 |
| Bollinger Bands (Upper/Lower) | $45.97/$40.32 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. BOUT |
Expenses vs. BOUT |
ALTAR Score™ vs. BOUT |
|---|---|---|---|---|
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 12.0% | -17 bp | -1.7% |
| FTC | First Trust Large Cap Growth AlphaDEX Fund | 11.3% | -22 bp | -1.2% |
| QMOM | Alpha Architect U.S. Quantitative Momentum ETF | 10.8% | -42 bp | -2.2% |
| KBE | State Street SPDR S&P Bank ETF | 10.7% | -46 bp | +5.6% |
Risk and Returns: BOUT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/9/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.8%
ALTAR SCORE™
22nd
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,207 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. BOUT's ALTAR Score™ is approximately -0.8 standard
deviations above the category average. This places BOUT in the 22nd percentile
among funds in the category.
Sell-Side Consensus
$46.21
PRICE TARGET
-0.2%
UPSIDE